Conquering Diseases

Study Of An Investigational Drug For Ovarian Cancer


Seeking women with ovarian cancer that progressed after at least 4 cycles of treatment with platinum-based chemotherapy for a study of an investigational drug.


All participants in this study will get the usual treatment for their cancer, but half of the participants will also get the investigational drug.

What we're hoping for

We hope to study whether adding the investigational drug to the usual treatment for platinum-resistant ovarian cancer improves the effectiveness of the usual treatment.

Additional Information Identifier: NCT04374630

 Principal Investigator

Susan  Zweizig, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655